Standout Papers

Development of potent monoclonal antibody auristatin conjugates for cancer therapy 2003 2026 2010 2018 888
  1. Development of potent monoclonal antibody auristatin conjugates for cancer therapy (2003)
    Svetlana O. Doronina, Brian E. Toki et al. Nature Biotechnology
  2. cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity (2003)
    Joseph A. Francisco, Charles G. Cerveny et al. Blood

Immediate Impact

12 by Nobel laureates 18 from Science/Nature 129 standout
Sub-graph 1 of 19

Citing Papers

Direct radical functionalization of native sugars
2024 StandoutNature
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
3 intermediate papers

Works of Brian E. Toki being referenced

Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery:  Effects of Linker Technology on Efficacy and Toxicity
2005
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity
2003 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Brian E. Toki 1406 1559 1123 15 2.8k
Svetlana O. Doronina 2183 2394 1392 27 3.7k
Joseph A. Francisco 1805 1904 1080 17 3.0k
Nicole M. Okeley 1378 1395 1231 37 2.7k
Dana F. Chace 1814 1877 1052 22 3.1k
Charles G. Cerveny 2402 2609 1404 26 4.0k
Tim D. Bovee 1408 1433 877 10 2.2k
Brian A. Mendelsohn 1444 1473 1015 39 2.6k
Roger F. Zabinski 1176 1380 801 11 2.1k
Yelena Kovtun 1437 1753 1750 44 4.1k
Wayne C. Widdison 1692 1751 1051 34 2.7k

All Works

Loading papers...

Rankless by CCL
2026